Skip to content
Disclosery

EXANE DERIVATIVES: CSCO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CSCO, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 23,175 CSCO shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 23,175 shares
    Change vs previous 13F +2,244 shares

    0.57% of the 13F portfolio, value $988,070.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 20,931 shares
    Change vs previous 13F -21,413 shares

    0.33% of the 13F portfolio, value $1,167,121.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 42,344 shares
    Change vs previous 13F -44,545 shares

    0.65% of the 13F portfolio, value $2,683,426.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 86,889 shares
    Change vs previous 13F +7,804 shares

    1.18% of the 13F portfolio, value $4,729,555.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 79,085 shares
    Change vs previous 13F +10,212 shares

    0.99% of the 13F portfolio, value $4,216,906.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 68,873 shares
    Change vs previous 13F +18,560 shares

    1.07% of the 13F portfolio, value $3,561,587.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 50,313 shares
    Change vs previous 13F -19,333 shares

    0.68% of the 13F portfolio, value $2,251,606.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 69,646 shares
    Change vs previous 13F not available

    0.89% of the 13F portfolio, value $2,743,430.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).